NCT02991508View on ClinicalTrials.gov

Adrecizumab Phase 1 Trial

PHASE1CompletedINTERVENTIONAL

Enrollment

24

Participants

Timeline

Start Date

May 23, 2016

Primary Completion Date

September 22, 2016

Study Completion Date

September 22, 2016

Conditions

Healthy Volunteers

Interventions

DRUG

Placebo

DRUG

Adrecizumab

Trial Locations (1)

6500HB

Radboudumc, Nijmegen

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Adrenomed AG

INDUSTRY

lead

Radboud University Medical Center

OTHER

NCT02991508 - Adrecizumab Phase 1 Trial | Biotech Hunter | Biotech Hunter